Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. formerly (OTC PINK:DIGP), has been approved to commence trading as Hypha Labs, Inc. (OTC PINK:FUNI) on August 13, 2024. Hypha Labs has...
Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production
Company Intends to Bring First Functional Mushroom Producer to Retail Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce...
Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications
Veteran Agency Brings Twenty-Five Years of Experience and Relationships to Emerging Functional Mushroom Science Company, a pioneer in functional mushroom sciences, is pleased to announce...
Hypha Labs Announces New Patent Filing
New Patent Portfolio Unveiled Revolutionizing Psilocybin Processing Hypha Labs, Inc. (OTC PINK:DIGP) Today marks a significant milestone in the realm of mycological innovation as Hypha...
Virdi, LLC Announces the Close of $7.5 Million Equity Financing
Virdi, LLC (“Virdi”) is pleased to announce the closing of a $7.5 million equity purchase by Beacon Hill Brands (USA) Inc. (“BHB”), which positions BHB...
Core One Labs’, Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
Core One's Wholly-Owned Subsidiary has filed a patent application with the United States Patent and Trademark OfficeVANCOUVER, BC / ACCESSWIRE / August 1, 2023 /...
Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds
VANCOUVER, BC / ACCESSWIRE / July 21, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN: A3CSSU) (the "Company" or "Core One") is pleased to announce...
Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing intravenous-infused...
Core One’s Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
VANCOUVER, BC / ACCESSWIRE / July 11, 2023 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the "Company") is pleased to announce that its...
Core One in Talks with Multiple Companies to Supply Psilocybin
VANCOUVER, BC / ACCESSWIRE / May 5, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6), (WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce that...